iSpecimen

iSpecimen Stock-Based Compensation

The Stock-Based Compensation (SBC) of iSpecimen (ISPC) as of Nov 5, 2026 is 21,266.00 USD. In the previous year, Stock-Based Compensation (SBC) was 249,675.00 USD — a change of -91.48% (lower).

Stock-Based Compensation

21,266.00USD

YoY

-91.48%

Last updated:

Stock-Based Compensation (SBC) of iSpecimen is 2025 21,266.00 USD. Stock-Based Compensation (SBC) of iSpecimen was 2024 249,675.00 USD. It decreases by -91.48% lower compared to the previous year.

The iSpecimen Stock-Based Compensation history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Stock-Based Compensation
Date
Stock-Based Compensation
Jan 1, 2018
113,921.00 USD
Jan 1, 2019
360,379.00 USD
Jan 1, 2020
92,866.00 USD
Jan 1, 2021
622,064.00 USD
Jan 1, 2022
678,613.00 USD
Jan 1, 2023
459,666.00 USD
Jan 1, 2024
249,675.00 USD
Jan 1, 2025
21,266.00 USD
The iSpecimen Stock-Based Compensation history
YEARStock-Based CompensationYoY
21,266.00USD-91.48%
249,675.00USD-45.68%
459,666.00USD-32.26%
678,613.00USD+9.09%
622,064.00USD+569.85%
92,866.00USD-74.23%
360,379.00USD+216.34%
113,921.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

iSpecimen Stock analysis

What does iSpecimen do? iSpecimen, Inc. generates revenue through its iSpecimen Marketplace platform, which connects healthcare providers with biospecimens to researchers in biopharmaceutical, in vitro diagnostic (IVD), and government/academic sectors. The platform consolidates biospecimen procurement by offering a single online marketplace where healthcare supply partners provide de-identified healthcare data, enabling researchers to search, manage workflows, and access administrative tools. Biopharmaceutical companies, IVD firms, and academic institutions purchase access to the platform’s data and services to accelerate medical discovery and streamline procurement processes. The company’s functional areas—search, workflow, data, and administration and reporting—support these transactions through integrated administrative and compliance management for all users. The iSpecimen Marketplace platform serves biopharmaceutical companies, in vitro diagnostic (IVD) companies, and government/academic institutions by providing a centralized hub for biospecimen procurement. Healthcare providers supplying biospecimens use the platform to list their collections, while researchers from the target sectors access the data for their studies. The platform’s de-identified healthcare data, compiled from healthcare supply partners, is a key asset that drives transactions. Administrative and reporting functions within the platform streamline operations for both suppliers and researchers, reducing manual effort and improving compliance. iSpecimen, Inc. monetizes its platform by facilitating connections between biospecimen suppliers and researchers across biopharmaceutical, IVD, and academic sectors. The company’s revenue comes from transactions and services provided through the iSpecimen Marketplace, which includes search capabilities, workflow management, data access, and administrative support. Healthcare supply partners contribute de-identified healthcare data to the platform, which researchers use to identify and procure necessary biospecimens for medical research and development. iSpecimen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about iSpecimen stock

Stock-Based Compensation (SBC) of iSpecimen is 21,266.00 USD in 2025.

Stock-Based Compensation (SBC) of iSpecimen changed from 249,675.00 USD to 21,266.00 USD, representing a -91.48% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Stock-Based Compensation (SBC) iSpecimen since 2006 – with annual values, charts, and detailed analysis.

Stock-based compensation is a non-cash expense representing equity awards to employees. High SBC can dilute existing shareholders and inflate reported cash flow.

Stock-Based Compensation (SBC)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Stock-Based Compensation (SBC)'s iSpecimen historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — iSpecimen

All Key Metrics — iSpecimen